Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MRG006A in advanced solid tumors
NCT07093970Phase 2Recruiting
- Sponsor
- Lepu Biopharma Co., Ltd.
- Start
- Jul 2024
- Primary completion
- Dec 2027
- Modality
- Antibody-Drug Conjugates (ADCs)
- Countries
- 1
01
Overview
A Phase 2 trial of MRG006A in solid tumor (advanced stage), sponsored by Lepu Biopharma Co., Ltd.. Started Jul 2024; status: recruiting.
02
Drugs
MRG006A
03
Conditions
solid tumor (advanced stage)
Beyond the preview
Go deeper on NCT07093970.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07093970.